Skip to main content

Table 5 Comparison of predictive performance between LODDS and other models

From: Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study

Model

IDI (95%CI)

P

NRI (95%CI)

P

1-year OS

 LODDS

Reference

 

Reference

 

 N classification

−0.007 (− 0.014 to − 0.002)

0.007

− 0.060 (− 0.122 to 0.002)

0.060

 Multivariable model

0.020 (0.012 to 0.031)

< 0.001

0.184 (0.114 to 0.250)

< 0.001

3-year OS

 LODDS

Reference

 

Reference

 

 N classification

−0.018 (− 0.030 to − 0.007)

< 0.001

− 0.049 (− 0.157 to − 0.001)

0.047

 Multivariable model

0.029 (0.017 to 0.045)

< 0.001

0.136 (0.096 to 0.196)

< 0.001

5-year OS

 LODDS

Reference

 

Reference

 

 N classification

−0.025 (− 0.040 to − 0.012)

< 0.001

− 0.074 (− 0.183 to − 0.025)

0.007

 Multivariable model

0.036 (0.024 to 0.057)

< 0.001

0.171 (0.126 to 0.224)

< 0.001

10-year OS

 LODDS

Reference

 

Reference

 

 N classification

−0.030 (− 0.050 to − 0.010)

< 0.001

−0.200 (− 0.290 to − 0.006)

0.027

 Multivariable model

0.056 (0.034 to 0.086)

< 0.001

0.258 (0.168 to 0.348)

< 0.001

  1. The multivariable model included LODDS, age, sex, T stage, and radiotherapy. LODDS, log odds of positive lymph nodes; OS, overall survival; IDI, integrated discrimination improvement; NRI, net reclassification improvement; CI, confidence interval